Clinical trial · Interventional
Sentinel Lymph Node Detection in Prostate Surgery by Laparoscopy
"Evaluation of the Sentinel Lymph Node Technic of the Prostate by Laparoscopy"
NCT01296217CI-TRIAL-00004510completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study the investigators want to determine if the detection of lymph node is applicable in prostatectomy by laparoscopy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Neoplasms | Prostate Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| lymph nod detection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- lymph nod detection
- interventionNames
- Procedure: lymph nod detection
Primary outcomes (1)
- measure
- detection rate and false-negative rate for the sentinel lymph node detection
- timeFrame
- The day of at laparoscopy (Day 1)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age\> 18 years * Diagnosis of invasive cancer of the prostate (T1 or T2 or T3) * PSA ≥ 4, * Gleason ≥ 6 * No treatment prior to surgery * Indication of lymphadenectomy by coeliscopique * ECOG or Karnofsky index 2 * Patient information and signed informed consent Exclusion Criteria: * neoadjuvant hormone therapy * Interventions prior pelvic * Patients who received anterior resection of part of prostate * Patient or denied having an altered mental status * Any contre indication to laparoscopy
References
Publications (0)
Data not yet available
No reference posted for this study.